Cargando…

Identification of Mutations Related to Cisplatin-Resistance and Prognosis of Patients With Lung Adenocarcinoma

Background: Lung adenocarcinoma (LUAD) is the most common histologic type of non-small cell lung cancer (NSCLC; approximately 60%), and platinum-based chemotherapy is the cornerstone of the treatment for patients with LUAD. However, a considerable number of patients experience tumor recurrence after...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Rui, Liu, Junfang, Fang, Zekui, Liang, Zhenyu, Chen, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658917/ https://www.ncbi.nlm.nih.gov/pubmed/33192515 http://dx.doi.org/10.3389/fphar.2020.572627

Ejemplares similares

Autophagy Inhibition Enhances the Anti-Tumor Activity of Methylseleninic Acid in Cisplatin-Resistance Human Lung Adenocarcinoma Cells
por: Xin, Ming, et al.
Publicado: (2022)

Prognosis of Lung Adenocarcinoma Patients With NTRK3 Mutations to Immune Checkpoint Inhibitors
por: Niu, Yuchun, et al.
Publicado: (2020)

XPC Protein Improves Lung Adenocarcinoma Prognosis by Inhibiting Lung Cancer Cell Stemness
por: Wang, Weiyu, et al.
Publicado: (2021)

Identification of a novel oxidative stress-related prognostic model in lung adenocarcinoma
por: Zhu, Yifan, et al.
Publicado: (2022)

Identification of solamargine as a cisplatin sensitizer through phenotypical screening in cisplatin-resistant NSCLC organoids
por: Han, Yi, et al.
Publicado: (2022)

Identification of cuproptosis-related subtypes in lung adenocarcinoma and its potential significance
por: Pan, Shize, et al.
Publicado: (2022)

USP22 Induces Cisplatin Resistance in Lung Adenocarcinoma by Regulating γH2AX-Mediated DNA Damage Repair and Ku70/Bax-Mediated Apoptosis
por: Wang, Aman, et al.
Publicado: (2017)

MMP9 Expression Correlates With Cisplatin Resistance in Small Cell Lung Cancer Patients
por: Wu, Longqiu, et al.
Publicado: (2022)

A Novel Immune-Prognosis Index Predicts the Benefit of Lung Adenocarcinoma Patients
por: Bai, Yuquan, et al.
Publicado: (2022)

Identification pyroptosis-related gene signature to predict prognosis and associated regulation axis in colon cancer
por: Zhou, Kexun, et al.
Publicado: (2022)

Inhibition of 6-phosphogluconate Dehydrogenase Reverses Cisplatin Resistance in Ovarian and Lung Cancer
por: Zheng, Wujian, et al.
Publicado: (2017)

Identification of novel immune-related molecular subtypes and a prognosis model to predict thyroid cancer prognosis and drug resistance
por: Zhang, Wei, et al.
Publicado: (2023)

Comprehensive genomics analysis of aging related gene signature to predict the prognosis and drug resistance of colon adenocarcinoma
por: Feng, Jubin, et al.
Publicado: (2023)

FDX1 can Impact the Prognosis and Mediate the Metabolism of Lung Adenocarcinoma
por: Zhang, Zeyu, et al.
Publicado: (2021)

Lung adenocarcinoma-related target gene prediction and drug repositioning
por: Huang, Rui Xuan, et al.
Publicado: (2022)

Characterization of lung adenocarcinoma based on immunophenotyping and constructing an immune scoring model to predict prognosis
por: Liu, Mengfeng, et al.
Publicado: (2022)

KIF20A is associated with clinical prognosis and synergistic effect of gemcitabine combined with ferroptosis inducer in lung adenocarcinoma
por: He, Hua, et al.
Publicado: (2022)

Predicting the Prognosis of Esophageal Adenocarcinoma by a Pyroptosis-Related Gene Signature
por: Zeng, Ruijie, et al.
Publicado: (2021)

Effect of Wenxia Changfu Formula Combined With Cisplatin Reversing Non-Small Cell Lung Cancer Cell Adhesion-Mediated Drug Resistance
por: Wang, Meng-Ran, et al.
Publicado: (2020)

Mutations Status of Chemokine Signaling Pathway Predict Prognosis of Immune Checkpoint Inhibitors in Colon Adenocarcinoma
por: Lin, Anqi, et al.
Publicado: (2021)

Molecular characterization based on tumor microenvironment-related signatures for guiding immunotherapy and therapeutic resistance in lung adenocarcinoma
por: Jie, Yamin, et al.
Publicado: (2023)

Prognosis and personalized treatment prediction in lung adenocarcinoma: An in silico and in vitro strategy adopting cuproptosis related lncRNA towards precision oncology
por: Ma, Chao, et al.
Publicado: (2023)

Integrative analysis illustrates the role of PCDH7 in lung cancer development, cisplatin resistance, and immunotherapy resistance: an underlying target
por: Li, Huakang, et al.
Publicado: (2023)

Function and prognostic value of basement membrane -related genes in lung adenocarcinoma
por: Zhang, Yurong, et al.
Publicado: (2023)

A Novel Integrated Metabolism-Immunity Gene Expression Model Predicts the Prognosis of Lung Adenocarcinoma Patients
por: Chen, Songming, et al.
Publicado: (2021)

A novel defined risk signature of cuproptosis-related long non-coding RNA for predicting prognosis, immune infiltration, and immunotherapy response in lung adenocarcinoma
por: Ma, Chao, et al.
Publicado: (2023)

Identification of Potential Biomarkers for Pan-Cancer Diagnosis and Prognosis Through the Integration of Large-Scale Transcriptomic Data
por: Zhu, Lin, et al.
Publicado: (2022)

Inhibition of Glucose-6-Phosphate Dehydrogenase Reverses Cisplatin Resistance in Lung Cancer Cells via the Redox System
por: Hong, Weipeng, et al.
Publicado: (2018)

Scutellarin Increases Cisplatin-Induced Apoptosis and Autophagy to Overcome Cisplatin Resistance in Non-small Cell Lung Cancer via ERK/p53 and c-met/AKT Signaling Pathways
por: Sun, Chao-Yue, et al.
Publicado: (2018)

Research Progress on the Functions and Mechanism of circRNA in Cisplatin Resistance in Tumors
por: Mu, Qingchun, et al.
Publicado: (2021)

Piperlongumine Inhibits Akt Phosphorylation to Reverse Resistance to Cisplatin in Human Non-Small Cell Lung Cancer Cells via ROS Regulation
por: Zhang, Chao, et al.
Publicado: (2019)

Case Report: PTEN Mutation Induced by anti-PD-1 Therapy in Stage IV Lung Adenocarcinoma
por: Teng, Junjie, et al.
Publicado: (2022)

Kynureninase knockdown inhibits cisplatin resistance in vivo and in vitro and impacts the prognosis of cervical adenocarcinoma
por: Zhang, Jun-wen, et al.
Publicado: (2023)

Construction of anoikis-related lncRNAs risk model: Predicts prognosis and immunotherapy response for gastric adenocarcinoma patients
por: Li, Qinglin, et al.
Publicado: (2023)

CLP1 is a Prognosis-Related Biomarker and Correlates With Immune Infiltrates in Rheumatoid Arthritis
por: Zhao, Zhenyu, et al.
Publicado: (2022)

Identification and experimental verification of an anoikis and immune related signature in prognosis for lung adenocarcinoma
por: Zhang, Jia-Le, et al.
Publicado: (2023)

Catenin Alpha-2 Mutation Changes the Immune Microenvironment in Lung Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitors
por: Wen, Yang, et al.
Publicado: (2021)

Erratum: Case report: PTEN mutation induced by anti-PD-1 therapy in stage IV lung adenocarcinoma
Publicado: (2022)

Case report: ALK D1225N missense mutation in lung adenocarcinoma responds to tyrosine kinase inhibitors
por: Chen, Jianxin, et al.
Publicado: (2023)

Acquired Concurrent EGFR T790M and Driver Gene Resistance From EGFR-TKIs Hampered Osimertinib Efficacy in Advanced Lung Adenocarcinoma: Case Reports
por: Zeng, Yue, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6vb58d5a9i7p8m75k4ln7irmjf